| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE | 214053 | 001 | ANDA | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | TABLET;ORAL | 120MG;EQ 15MG BASE | No | No | 2024/05/17 | 2024/05/17 | APOTEX | Discontinued |
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE | 214053 | 002 | ANDA | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | TABLET;ORAL | 200MG;EQ 25MG BASE | No | No | 2024/05/17 | 2024/05/17 | APOTEX | Discontinued |
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE | 213926 | 001 | ANDA | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | TABLET;ORAL | 200MG;EQ 25MG BASE | No | No | 2024/12/13 | -- | LUPIN LTD | Prescription |